Ready to Invest?™ in Las Vegas, Nevada – December 10, 2019

READY TO INVEST? TM ARCVIEW PRESENTS Las Vegas, Nevada – December 10, 2019

2

The Arcview Group / Las Vegas, NV - 12.10.2019

The cannabis market has immeasurable potential, and Arcview combs through the space and identifies potential candidates from among hundreds of emerging companies. troy dayton founder, the arcview group

3

The Arcview Group / Las Vegas, NV - 12.10.2019

the arcview investor network

We created the Investor Network to connect accredited investors with exceptional cannabis companies. But to truly succeed, you need more. This is why, when you join the Arcview Investor Network, you become part of a curated community of high net- worth individuals, institutional investors, leading brands, entrepreneurs, and money managers. Access to the shared wisdom of 650+ other Investor Network members, gives you the advantage in a sector unlike most others. Our promise is simple. To help you navigate and profit from the historic cannabis opportunity with exceptional deal-flow, unsurpassed networks, and the industry leading research. Founded in 2010 and listed recently by Forbes as one of the top five financial firms in the cannabis industry, investors in the Arcview Investor Network have invested more than $270 million in over 200 companies. Because Going It Alone, Seldom Leads to the Best Investments

Access Vetted Deal Flow

Collaborate on Due-Diligence

Invest in Future Industry Titans

Participate in Private Investment Summits

Form Relationships with Leading Cannabis Investors

4

The Arcview Group / Las Vegas, NV - 12.10.2019

upcoming event

2020VISION: Cannabis Investing for a New Decade Savvy Cannabis Investors & Operators are Joining Arcview in Los Angeles February 4-6, 2020 Santa Monica, Fairmont Miramar & Bungalows Exclusive member’s only event for Institutional & Accredited Investors

For more information: info@arcviewgroup.com events.arcviewgroup.com

Scan the QR Code for Details

5

The Arcview Group / Las Vegas, NV - 12.10.2019

Meet Arcview's Investor Member Dinner Sponsor: Philter Labs, Inc.

PHILTER LABS, INC., is a Southern California based technology company creating science-based solutions to reduce the harmful effects of vaping and smoking, with products that encourage conscientious practices that minimize the impact of exposure to vaping and smoking. The company started with the mission to eliminate second- hand smoke and vape, and invented patented “ZERO-5” technology -- a five-step, nanofiltration process that molecularly manipulates secondhand vape and smoke to reduce emissions; all encapsulated in the world’s first hand-held filter measuring at a mere 4 INCHES tall and ½ INCH wide. ZERO-5 is just the beginning and core to new solutions the company plans to commercially reveal in 2020. The company added two renowned toxicologists, Dr. Willie J. McKinney, Ph.D., D.A.B.T. and Dr. Michael S. Werley, MS, Ph.D., D.A.B.T. to its Strategic Scientific Advisory Board (SSAB). Both

have over 40 years of executive leadership experience at Altria, JUUL, and Philip Morris and have developed new, better and compliant products for some of the largest and most sophisticated companies in the e-cigarette space. The Company recently began selling its products online and secured large scale distribution with Greenlane, ReCreation Marketing, WAYV, and Amazon. The company expects to exceed $500,000 this year, and will grow to over $2.2 million in 2020, driven by expanding distribution and new products scheduled to launch in 2020. Total capital raised by Philter Labs is $2.1 million (Bravos Capital, Explorer Equity, Holonis Media Group), including $1 million equity at a $12 million valuation in June 2019 (Greenfield Global Opportunities Fund). The Company is currently seeking $1 million in equity funding to support new product engineering and product launches, and anticipates a Series A round in mid to late 2020.

6

The Arcview Group / Las Vegas, NV - 12.10.2019

The Agenda

Opening Remarks Troy Dayton, Founder, The Arcview Group

1:00 PM

Special Video Feature from BDS Analytics

1:20 PM

Keynote Address: Tim Seymour, CIO, Seymour Asset Management

1:25 PM

READY TO INVEST? TM Introduction & Voting Rules

1:40 PM

Meet the READY TO INVEST? TM Session 1 Judges Panel Andi Goldman, Equitas Partners Brent Johnson, Hoban Law Chanda Macias, Women Grow & National Holistic Center READY TO INVEST? TM Session 1 Begins Entrepreneurs and Operators present their companies Live on Stage to Investors Sunderstorm Keith Cich, Co-Founder Nuka Enterprises (1906) Peter Barsoom, CEO Guild Extracts Steve Felter, CEO & Claudio Miranda, CMO fumé Eric Sklar, CEO

1:55 PM

Arcview READY TO INVEST?™️ is a turbo-charged, rapid-paced group of highly-curated pitch presentations to accredited investors of early-stage and start- up cannabis companies. The on-stage pitches must deal with challenging live expert judges as well as audience participation balanced by our savvy host. There is real money at stake here – each Ready to Invest?™️ event’s best pitch receives an Arcview investment.

2:00 PM

15 Minute Intermission Coffee Served

3:10 PM

7

The Arcview Group / Las Vegas, NV - 12.10.2019

Meet the READY TO INVEST? TM Session 2 Judges Panel Jamie Pearson, Bhang Corporation Khurshid Khoja, Greenbridge Corporate Counsel Rod Stephan, Altitude Investment Management READY TO INVEST? TM Session 2 Begins Entrepreneurs and Operators present their companies Live on Stage to Investors

3:25 PM

3:30 PM

Conception Nurseries Kevin Brooks, CEO Pineapple Express Delivery Randy Rolph, CEO Landrace Biosciences John DeMoss, CEO Accession BioSciences, Inc. Gary Binyamin, Co-Founder

Recap and Final Voting Vote for the company who delivered the Best Pitch. The top ranked presenter will receive $25,000 SAFE note (or similar investment), pending due diligence.

4:45 PM

Closing Remarks & Looking to the Future

5:00 PM

READY TO INVEST?™️ by Arcview

NOTES

brings cannabis investing to life.

8

The Arcview Group / Las Vegas, NV - 12.10.2019

Help us select the Best Pitch Award Winner

HOW TO VOTE – Visit Slido.com – Enter code LV19

– Rank the top pitches – Post live questions

The top ranked company will receive $25,000 SAFE note (or similar investment), pending due diligence.

THE ARCVIEW GROUP

9

The Arcview Group / Las Vegas, NV - 12.10.2019

A MUST HAVE FOR CANNABIS INVESTORS

The 7th edition of our flagship report gives you access to the latest analysis and trends so you may make more informed decisions about your involvement in the space. Often revered as the Industry Bible, this is a mission- critical investment tool for evaluating dealflow. ■ Hardbound "coffee-table" volume within 2 weeks of release ■ Digital access to the 400+ page report ■ 250+ data-rich graphs, charts and tables ■ Downloadable slides of select charts for your presentations ■ Semi-annual update sent digitally

SPONSORED BY lHanideal � Cam,.,;, roam CANNAS�RE MAZAKAU

FOR MORE VALUE, GET THE INDUSTRY BIBLE WITH AN ANNUAL CIB SUBSCRIPTION Subscribe to the Cannabis Intelligence Briefing (CIB) Series and gain access to each new report as they're published plus the entire catalog of past briefings. CIB reports offer in-depth data and analysis on focused topics such as Concentrates, Cannabinoids, and the California Market. As part of your subscription, you'll also receive a copy of the most recent The State of Legal Cannabis Markets.

Canada Mower: 'II 'lhe fas1:r lhe Wa� i:oundali1 1-'ulure of <:annabi Cannabis Cannabis Edibks

EXCLUSIVE OFFERS FOR MEMBERS OF THE ARCVIEW INVESTOR NETWORK For even greater value, ask about our membership packages combining the advantages of the Arcview Investor Network with the resources of Arcview market research reports. The level of insights you'll obtain through data, a proprietary investment platform, and the personal connections you'll make will not only help you make better investment decisions, but also avoid crucial investment pitfalls.

IN PARTNERSHIP WITH Qfr>Analytics

10

The Arcview Group / Las Vegas, NV - 12.10.2019

Timothy Seymour KEYNOTE SPEAKER CIO of Seymour Asset Management & Member of CNBC’s Fast Money

Tim Seymour is founder and Chief Investment Officer of Seymour Asset Management (SAM). SAM provides both asset management and wealth management services for its clients, including direct investment and allocation to private equity and alternative assets. Tim is also the Portfolio Manager of the Amplify Seymour Cannabis ETF ticker: $CNBS. Tim has over 22 years of investment experience as a portfolio manager, allocator and capital markets professional across multiple asset classes. Tim is a recognized voice within the investment community as a trader and market strategist on CNBC. For over a decade, Tim has been a primary investor voice on CNBC’s Fast Money. Tim is often cited as one of the top finance professionals on Twitter, including The Wall Street Journal’s “Top Tweets For Your Money”. Tim was the CIO and co-founder of Triogem Asset Management where the firm’s flagship fund was a long short global emerging market equity strategy. Triogem’s investment approach was rooted in running a low volatility portfolio that managed top down risks while employing a rigorous research process to bottom up stock picking. Prior to Triogem, Tim was co-founder and Managing Partner at Red Star Asset Management (Moscow, New York), where he ran a core strategy emphasizing low volatility, multi-strat fund investing across Russia/Eastern Europe.

11

The Arcview Group / Las Vegas, NV - 12.10.2019

Before launching Red Star, Tim was a Partner and Managing Director at Troika Dialog, Russia’s largest investment bank in Moscow. At Troika, Tim served in various roles including running fixed income sales and trading and launching the firm’s US broker/ dealer and overseeing all US capital markets activity. Tim started his career at UBS in New York, focusing on international macro (cash bonds, swaps, forex). Tim completed the firm’s capital markets training program after graduating with an MBA in International Finance from Fordham University. Tim received his undergraduate degree at Georgetown University. Tim is an Advisor to the regulated firm The Benchmark Company on selected investment banking transactions. Tim acts in an advisory capacity to multiple cannabis companies and all his disclosures can be found below. Tim serves as an Advisory Board Member for The Georgetown Wall Street Alliance. Tim lives in New York City with his wife and two children. When he is not with his family, Tim is playing drums and singing in his two bands.

It’s fascinating to see the early stages of a new growth industry, unlike anything we’ve seen since the initial Internet boom. Helping this next wave of entrepreneurs to connect with the right people and make smart decisions through Arcview is about as exciting as it ever gets. I’m proud to be a part of it.

Follow Tim on Twitter: @timseymour

www.seymouram.com

timothy seymour

12

The Arcview Group / Las Vegas, NV - 12.10.2019

Featured Companies Take a closer look at the READY TO INVEST? TM pitching companies

Nuka Enterprises (1906) Peter Barsoom – CEO

Our company is pioneering ways to deliver NON-SMOKABLE controlled doses of cannabis and plant medicines in safe, discreet and user-friendly formats that enable cannabis to become a wellness tool and a performance-enhancing “supplement.” There is a vast untapped segment of people who are interested in health and wellness, but have yet to discover cannabis as a crucial tool in their self-care routine. 1906 straddles the cannabis market and the overall health and wellness market by creating finely tuned formulas that enhance the most important parts of high-functioning adults’ lives – sleep, sex, energy, cognitive focus, relaxation, and mood. www.1906newhighs.com

Accession BioSciences, Inc. Gary Binyamin – CEO

Accession BioSciences, Inc.

Accession BioSciences, Inc. solves the challenge of delivering pure, predictable dosing of cannabinoid formulations. The proprietary active release formulation improves bioavailability and controls the amount, on-set time, and duration of delivery. The technology is initially intended to target consumer CBD formulations, with potential future application to pharmaceutical or medicinal formulations. www.accessionbio.com

Conception Nurseries Kevin Brooks – CEO

Conception is bringing tissue culture technology (or micropropagation) to the cannabis industry. To date, cultivators have been dependent on “mom plants” to produce “clones” that deliver inconsistent harvests with diluted and uncontrollable traits. This also results in cultivators being unable to accurately forecast production and the end user not being able to depend on a consistent experience. Tissue culture technology, which is widely used in industrial agriculture to solve these exact problems facing cannabis cultivators today, allows Conception to quickly mass produce identical plantlets that are disease-free and have customized and consistent profiles. This reduces cultivators’ operational risks and costs and increases revenues while delivering a dependable experience for the end user. We sell clean, healthy, vigorous plantlets to commercial cultivators. By the end of 2020 we are projected to be of the largest producer of plants on the West Coast. www.conceptionnurseries.com

fumé Eric Sklar – CEO

fumé is a vertically integrated cannabis company based in Napa Valley. The management team has a combined experience of over 70-years as brand creators in the restaurant, winery, and now cannabis industries. In cannabis, fumé operates four businesses from cultivation through retail. But, first & foremost, fumé is a brand creation company. www.fumebrands.com

13

The Arcview Group / Las Vegas, NV - 12.10.2019

Guild Extracts Steve Felter – CEO

Guild Extracts is a premium California extracts brand, renowned for pioneering award-winning concentrates for the cannabis connoisseur since 2015. Guild utilizes patented processes to efficiently manufacture high-terpene extracts, full-spectrum cartridges, molecular isolates, and medical-grade tablets that can be found in over 200 dispensaries and delivery services statewide. www.guildextracts.com Landrace Biosciences John DeMoss – CEO Landrace is a hemp ingredient manufacturer addressing the needs of existing manufacturers in their product development efforts. www.landracebio.com

Pineapple Express Delivery Randy Rolph – CEO

Pineapple Express Delivery is a fully compliant same day distribution solution for the Canadian cannabis industry. Launched in 2018, this award winning company has extended its unique offering across Canada provides same day delivery for both the recreational and medical markets (B2C and B2B). www.pineappleexpressdelivery.com

Sunderstorm Keith Cich – CEO

Founded by Stanford grads with extensive business experience, Sunderstorm manufacturers a broad array of concentrate products (gummy candy, vape pens, nano-molecular sublingual sprays) for wholesale distribution to dispensaries and delivery services. As a leading lifestyle brand with over 330 clients from San Diego to Redding, the Company currently generates approx $1,300,000 in monthly sales. www.sunderstorm.com

14

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.1906newhighs.com

Entrepreneur Peter Barsoom pbarsoom@nukafoods.com Round Overview Current Round: Series A Company Stage: Between $1M and $5M in revenue Raised In This Round: $6,000,000 Capital Seeking: $12,000,000 Direct Investment Min.: $100,000 Valuation: $48,000,000 Security Type: Preferred Equity Touching the plant: yes Company Team

Nuka Enterprises / 1906 Consumer Products – Denver - Colorado - US

company summary

What customer problem does your product/ service address? Since legal cannabis began, the broadest range of product options and the most expert customer service have centered on smokables. But carcinogens and lung damage should not be the price of entry for the benefits of cannabis. The vast majority of cannabis consumers don’t want to “get high”; they want to use cannabis to address specific conditions. As legalization expands, more and more consumer... Our company is pioneering ways to deliver NON-SMOKABLE controlled doses of cannabis and plant medicines in safe, discreet and user-friendly formats that enable cannabis to become a wellness tool and a performance- enhancing “supplement.” There is a vast untapped segment of people who are interested in health and wellness, but have yet to discover cannabis as a crucial tool in their self-care routine. 1906 straddles the cannabis market and the overall health and wellness market by creating finely tuned formulas that enhance the most important parts of high-functioning adults’ lives – sleep, sex, energy, cognitive focus, relaxation, and mood. 1. The fastest-acting edible on the market. Patented lipid microencapsulation technology delivers onset time of 20 minutes or less. 2. Superior taste owing to novel technology, artisanal ingredients, and world-class chocolate-making technique. 3. Targeted experiences surpass the ambition of any other edibles brand. 4. A wide range of consumption options creates flexible usage with high- functioning adults in mind. executive summary

Peter Barsoom – CEO Full time employees: 40

1906 is on a mission to redefine the edibles market with functional highs that offer the fastest activation on the market, ingredients of unprecedented quality

15

The Arcview Group / Las Vegas, NV - 12.10.2019

Describe your product/service and detail the key customer benefits 1906 straddles the cannabis market and the overall health and wellness market by creating finely tuned formulas that enhance the most important parts of high-functioning adults’ lives – sleep, sex, energy, cognitive focus, relaxation, and mood. Describe the competitive landscape and your competitor’s strengths and weaknesses Edibles take 60-90 minutes to kick and are undifferentiated in their effect. Describe what makes your solution unique, and what your competitive advantages are 1. PLANT POWER Six different thoughtful formulations of super powerful adaptogens and herbs plus socially dosed cannabis. 2. RAPID ONSET Proprietary technology for the fastest onset in the market: 20 minutes or less. 3. OPTIMAL RATIOS OF CBD TO THC Our ratios of CBD to THC are 1:1 for most products and 5:1 for our relaxing formula. 4. QUALITY FIRST All 1906 products use single-strain, pesticide-free cannabis and are triple tested for consistency 5. INCREDIBLE FLAVOR Our delicious art... Describe your target market, and who your customers are, and why you’re targeting them High functioning adults for whom cannabis could be an alternative to alcohol or pharmaceuticals. How will you use investment capital to grow your business, and what would the key milestones of success be? Opening Massachusetts, Michigan and Illinois Besides capital, what are you seeking from investors and potential strategic partners? N/A Describe the cannabis laws in your state and country that relate to your Company Adult use markets Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? No

Explore more information about Nuka Enterprises / 1906 at https://breezeinvesting.com/1466

16

The Arcview Group / Las Vegas, NV - 12.10.2019

Accession BioSciences, Inc.

Entrepreneur Gary Binyamin gbinyamin@accessionbio.com Round Overview Current Round: Series A Company Stage: Prototype/Beta ready Raised In This Round: $0 Capital Seeking: $2,000,000 Direct Investment Min.: $500,000 Valuation: $8,000,000 Security Type: Common Equity Touching the plant: no Company Team Gary Binyamin, PhD – COO Eitan Konstantino, PhD – Co-Founder, Board Member Juny Sridhara, MBA – CEO Full time employees: 3

Accession BioSciences, Inc. Consumer Products – Berkeley - California - US

company summary

Accession Biosciences, Inc. solves the challenge of delivering pure, predictable dosing of cannabinoid formulations. The proprietary active release formulation improves bioavailability and controls the amount, on- set time, and duration of delivery. The technology is initially intended to target consumer CBD formulations, with potential future application to pharmaceutical or medicinal formulations.

executive summary

What customer problem does your product/ service address? Accession Biosciences, Inc. solves the challenge of pure, predictable dosing of cannabinoid formulations with an initial focus on cannabidiol (CBD). For customers this is embodied by a product that provides for efficient delivery, yielding the expected effect with minimal safety concerns. Purity and sourcing of CBD products are a primary challenge that manufactures currently need to address. Mo... Describe your product/service and detail the key customer benefits The proprietary ingestible formulations developed by Accession Biosciences, Inc. allow for improved uptake controlled on-set, and defined durability of CBD effect; yielding some of the most reliable and repeatable products on the market. Through precision delivery technology the company avoids the dosage variation common in other products, which can, at best, have no effect and, at worst, cause harm...

Making the CBD products you buy better

17

The Arcview Group / Las Vegas, NV - 12.10.2019

Describe the competitive landscape and your competitor’s strengths and weaknesses There are hundreds of first generation CBD consumer products on the market. Through first-mover advantage, these products and markets have been formed and a customer-base established for CBD products. Yet the landscape and manufacturing processes for these products are highly fragmented and var... Describe what makes your solution unique, and what your competitive advantages are Accession Biosciences, Inc. brings 3 unique advantages together: technology, team, and partners. The core technology developed by the company allows for increased bioavailability and solubility of its formulations. Combined with unique transport conditions, this allows for rapid-onset and extended durability of effect. Initial characterization demonstrates improved properties of the Accession Biosciences, Inc. CBD over the as-received isolate material and tissue uptake studies suggest improved bio... Describe your target market, and who your customers are, and why you’re targeting them The CBD consumer products market was reported to be $327M in 2017 and is expected to exceed $25B by 2025 (https:// www.statista.com/statistics/760498/total-us-cbd-sales/, accessed Oct 7 2019). Broadly this market is highly fragmented with numerous small players. Accession Biosciences, Inc. will initially focus on the food & beverages segment, which represents approximately one-third of the total market. Customers are self-motivated to adopt CBD-based products and are seeking out the effects t... How will you use investment capital to grow your business, and what would the key milestones of success be? The investment will allow for the company to establish a laboratory and personnel to compliment the current team. Milestones include optimizing and scaling the formulation, benchmarking against currently marketed CBD products, collecting user feedback, and promoting the technology towards the manufacturing stage. Simultaneously, a partnership milestone with a major CPG partner will be finalized for sales and distribution. Besides capital, what are you seeking from investors and potential strategic partners? Generally, building a company requires the ability to form solid partnerships and meaningful relationships. These contribute to anticipated and unanticipated opportunities during the lifecycle of a company. The Accession team brings a strong technical background and scientific approach to the delivery of CBD-consumer products. We seek to partner with investors and others on a variety of topics in which they have established expertise. These could include up-stream materials sourcing, dist... Describe the cannabis laws in your state and country that relate to your Company There is a significant amount of discussion across US government levels (federal, state, and local) about CBD products. Enforcement has been minimal and sporadic, with a general lack of clarity around the status of these products. The FDA is committed to making decision based on scientific principals, having held an informational meeting in early 2019 and committing to a future guidance document on the topic. Former commissioner Gottlieb has advocated for the elucidation of both safety ... Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? Accession Biosciences, Inc. believes that the CBD- market will be well defined and meaningful independent of further cannabis legalization. This is the initial target for the company. The delivery technologies being developed will be adapted to other cannabinoids. Not only controlled, micro-dosing of THC but there are a host of other cannabinoids that have been demonstrated to have clinica... What else? Is there anything else you’d like to share with investors to help them consider your investment? The founders of this company come from well-established, successful accomplishments in related fields. Independently, we identified the cannabis market as the place to invest the time and resources required to build a company. As the founders came together to discuss Accession Biosciences, Inc., it was evident that there was a dedication and commitment to providing a best-in-class product for th...

Explore more information about Accession BioSciences, Inc. at https://breezeinvesting.com/1962

18

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.conceptionnurseries.com Entrepreneur Kevin Brooks kbrooks@conceptionnurseries.com Round Overview Current Round: Series A Company Stage: Full Product/Service ready for launch Raised In This Round: $10,000,000 Capital Seeking: $15,000,000 Direct Investment Min.: $50,000 Valuation: $40,000,000 Security Type: Common Equity Touching the plant: yes

Conception Nurseries AgTech – Sacramento - California - US

company summary

Conception is an early leader solving some of cultivators' trickiest problems by bringing tissue culture technology (or micropropagation) to the cannabis industry. To date cultivators have been dependent on “mom plants” to produce “clones” that unfortunately deliver inconsistent harvests with diluted and uncontrollable traits. This results in cultivators not being able to accurately forecast production and end user not being able to depend on a consistent experience. Tissue culture technology, which is widely used in industrial agriculture to solve the problems cannabis faces today, allows Conception to quickly mass produce identical plantlets that are disease- free and have customized and consistent profiles. This reduces cultivators' operational risks and costs and increases revenues while delivering a dependable experience for the end user. What customer problem does your product/ service address? Conception is an early leader solving some of cultivators' trickiest problems by bringing tissue culture technology (or micropropagation) to the cannabis industry. To date, cultivators have been dependent on “mom plants” to produce “clones” that deliver inconsistent harvests with diluted and uncontrollable traits. This also results in cultivators being unable to accurately forecast production a... Describe your product/service and detail the key customer benefits To date, cultivators have largely been dependent on “mom plants” to produce “clones” resulting in inconsistent harvests with diluted and uncontrollable traits. Our sell small plants that have consistent yields and executive summary

Company Team Kevin Brooks – CEO Tad Henderson – COO Full time employees: 25 Social

Twitter: https://twitter.com/conceptionnurs LinkedIn: https://www.linkedin.com/company/ conceptionnurseries/?viewAsMember=true

Conception is bringing tissue culture technology at scale to the cannabis industry

19

The Arcview Group / Las Vegas, NV - 12.10.2019

grow times and are pest and disease free as they are created in lab conditions. In addition, the removal of the “mom rooms” frees up cultivators’ valuable, licensed real estate. We ... Describe the competitive landscape and your competitor’s strengths and weaknesses There are a few groups that have recognized tissue culture as the future of cannabis cultivation. Our focus at Conception is not only to provide a far superior plant than traditional propagation but to do so at or below what it would cost for a cultivator to do in-house. The only way to achieve t... Describe what makes your solution unique, and what your competitive advantages are We have made significant investments in the newest lab production technology that will allow us to put out a far more consistent product at or below what it would cost a cultivator to do in-house. Describe your target market, and who your customers are, and why you’re targeting them The size and growth rate of the market is detailed in our pitch deck. In sum, the micropropagation market is projected to increase at a 32.8% CAGR and reach $734M in 2022. Our customers are licensed cultivators of any size but we have had particular traction with mid-size and large cultivators as they are excited about the technology and quickly understand how our products transform a cost center into a profit center. How will you use investment capital to grow your business, and what would the key milestones of success be? Conception’s state-of-the-art Oregon facility is fully operational and has already begun delivering product to that market. Conception’s California facility is under construction and is slated for completion in Q1 2020. With a production capacity of over 6M million plants per year (much of which are currently spoken for under LOIs) Conception will the largest cannabis plant provider in the West Coast. Conception has also identified its next facility in Massachusetts where construction is exp... Besides capital, what are you seeking from investors and potential strategic partners? Introductions to MSO and other commercial cultivators Describe the cannabis laws in your state and country that relate to your Company We are operating in Oregon with facilities scheduled to open in Massachusetts (Q4 2020) and California (Q1 2020). All 3 states allow for cannabis cultivation. Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? Recreational use will open us up to a broader market. What else? Is there anything else you’d like to share with investors to help them consider your investment? Conception Nurseries revenue streams will be heavily weighted from recurring revenue. As customers are able to transition away from “Mom Rooms” they will need to source clones on a recurring basis. We have modeled our revenue assumptions as a factor of our production capabilities. The scale of each facility will drive plant output and we are targeting markets where our production when fully sol...

Explore more information about Conception Nurseries at https://breezeinvesting.com/2051

20

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.fumebrands.com Entrepreneur Eric Sklar

fumé (Napa Valley Fumé, LLC) Consumer Products – Clearlake - California - US

eric@fumenapa.com Round Overview Current Round: Series A Company Stage: Over $5M in revenue Raised In This Round: $1,000,000 Capital Seeking: $10,000,000 Direct Investment Min.: $250,000 Valuation: $50,000,000 Security Type: Common Equity Touching the plant: yes Company Team Eric Sklar – CEO Elissa Hambrecht – COO Ian Hackett – CTO + CMO James Bailey – Trustee & 1st Investor Full time employees: 58 Social Facebook: https://www.facebook.com/ fume.highroad/ Twitter: https://www.twitter.com/fume_napa LinkedIn: https://www.linkedin.com/company/ 28466204

company summary

What customer problem does your product/ service address? For products like cannabis there is the opportunity for many brands to do well. To thrive, however, one needs to have a deep understanding of the market segmentation for cannabis and be able to deliver an authentic experience to the targeted segments. By leveraging our access to the Eaze platform, we are in a unique position to analyze and act using market data. This allows us to identify the b... fumé (Napa Valley Fume, LLC) is a vertically integrated cannabis company founded by Eric Sklar (CEO) and Elissa Hambrecht (COO). This management team has the combined experience of over 70-years as entrepreneurs in the restaurant, winery, and now cannabis industries. In cannabis, fumé operates four companies from cultivation through retail. fumé recently opened a series A round. fumé’s first harvest was complete in November 2018, which yielded roughly 1,300 pounds of production off of a half- acre. The crop was excellent, with high potency and clean test results. Approximately two-thirds of the crop sold at a 100%+ markup relative to COGs and the remainder was used to launch our first proprietary brand: LAKEGRADE. fumé owns and/or has pending registration for state and federal trademarks for three brands, fumé, GRADE & Symphony. fumé’s “super power” is a combination of three elements: • Extensive experience in luxury branding in the wine industry • Unparalleled access + knowledge in political circles • GSD – Get Shit Done! executive summary

fumé is a vertically integrated cannabis company operating four businesses from cultivation through retail.

21

The Arcview Group / Las Vegas, NV - 12.10.2019

Describe your product/service and detail the key customer benefits While many in the space are chasing the latest shiny object, we believe that flower and pre-rolls for recreational use will continue to represent a large part of the overall market. So, we start with craft cultivation of our plants, which we grown 100% outdoor. These trees are sun-grown, full term, and at harvest yield up to 10lbs of premium cannabis each. But creating great product is just the... Describe the competitive landscape and your competitor’s strengths and weaknesses We believe that in these early days of the legal industry there are plenty of opportunities and lots of blue sky. Rather than focusing on the competition and the wheel spin of chasing after another company we want to focus on our development as a world class company. We also keep a keen eye on ... Describe what makes your solution unique, and what your competitive advantages are One of our key competitive advantages is our access to regulators and the experience to understand how to navigate in the world of licenses and compliance with state and local laws. While our approach may not be unique, our vision has not wavered since our launch. Lots of people talk about vertical integration leading to brand launch, but we executed and achieved a lot in a very short amount of time, on a relatively small amount of capital. Describe your target market, and who your customers are, and why you’re targeting them We are targeting cannabis consumers in CA. We are very happy to be operating in the world’s largest market and believe that this positions us to be a dominant national brand when inner-state commerce becomes legal. How will you use investment capital to grow your business, and what would the key milestones of success be? To launch our three brands and to be able to take advantage of strategic acquisitions. Besides capital, what are you seeking from investors and potential strategic partners? Money is generic, expertise and networks are not. We are looking for investors who have a mature role in the space and can bring all that a true VC firm can – top level advice on all aspects of the business, deep financial expertise, and a broad network that can provide both tactical and strategic advantage. Describe the cannabis laws in your state and country that relate to your Company Being in California, we are able to take advantage of a fully legal market and have been able to use our super powers in public policy to help create a favorable regulatory environment where we operate. Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? California has already launched both medical and recreational. It is a real advantage to be in the largest legal market in the world and we are taking advantage of all that entails. We will also, through licensing arrangements, launch in a two to three other states in the coming year. But, ultimately, being in the California market will allow us to scale and be prepared for the ultimate scaling... What else? Is there anything else you’d like to share with investors to help them consider your investment? fumé was founded and is run by a team with a truly unique combination of past experiences: in successful brand building, specifically in the wine industry, which has several synergies with the emerging legal cannabis space. Additionally, we have deep policy experience and the kind of relationships that allow us not to just navigate the complex regulatory environment that surrounds cannabis, bu...

Explore more information about fumé (Napa Valley Fumé, LLC) at https://breezeinvesting.com/1957

22

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.guildextracts.com Entrepreneur Steve Felter steve@guildextracts.com

Guild Extracts Consumer Products – Oakland - California - US

Round Overview Current Round: Seed Company Stage: Between $1M and $5M in revenue Raised In This Round: $2,500,000 Capital Seeking: $5,000,000 Direct Investment Min.: $250,000 Cap Valuation: $14,500,000 Security Type: Convertible Debt Touching the plant: yes

company summary

What customer problem does your product/ service address? Guild Extracts develops award-winning extracts for the cannabis connoisseurs at competitive prices in the premium segment. Describe your product/service and detail the key customer benefits Industry-leading, patented processing techniques for isolating cannabinoids and terpenes maintain “true strain” aromatic and flavor profiles for a variety of popular extract SKUs. isolates (THCA, Delta-8, CBD, CBDA, CBN); high-terpene extracts (Sauce, Batter, Sugar, etc); cartridges (High Potency, Full Spectrum “Sauce”, Delta-8, CBD Ratios); and medicinal tablets (THCA, CBD, CBN). We also offer a suite of contract manufacturing services to a selection of premium brands. Guild Extracts is distributed in over 200 dispensaries and delivery services statewide, including the Eaze platform. We recently entered into a partnership with Calyx Distribution to expand our footprint across their network of 550 retail stores. Our growth strategy is focused on solidifying our brand position in California then expanding into additional markets. executive summary Established in 2015, Guild Extracts is a California-based “legacy” brand that offers premium concentrates to the cannabis connoisseur. Our patented techniques for isolating cannabinoids and terpenes are more efficient and scalable than the competition and have established our reputation as early innovators and market leaders in the field of extraction science. Our suite of award-winning products includes:

Company Team Steve Felter – CEO

Claudio Miranda – CMO Full time employees: 15 Social Instagram: https://www.instagram.com/ guild_extracts_/

Guild Extracts is a premium California concentrates brand,

beloved by connoisseurs of high-grade and exotic concentrates.

23

The Arcview Group / Las Vegas, NV - 12.10.2019

Describe the competitive landscape and your competitor’s strengths and weaknesses The CA concentrate market is currently dominated by low-priced competition with little product differentiation. Raw Garden dominates the dabbable extract category with its low-priced Sauce SKU, while the Vape category is dominated by low-priced offerings from companies like Select. Guild has ... Describe what makes your solution unique, and what your competitive advantages are We have several patents covering our post-processing techniques which enable us to create our signature products at a lower cost with greater efficiency. We’ve been first to market with multiple new products (THCA, Delta) and will continue to prioritize innovation in order to maintain our headstart. Describe your target market, and who your customers are, and why you’re targeting them Historically we’ve targeted the “cannasseur” extract market in California, which is currently a relatively small, but influential audience. Our strategy is to build a luxury brand based on high-quality, aspirational products. Once the premium reputation was established, we began targeting more mainstream cannabis consumers with more approachable products (e.g. vape, tablets) and leveraging the premium reputation. How will you use investment capital to grow your business, and what would the key milestones of success be? For our Series A, we’re aiming to increase our annual run rate from $3.5M to $5-10M and grow our customer base from 200 to over 300. Besides capital, what are you seeking from investors and potential strategic partners? Distribution and manufacturing assets/relationships outside of CA, supply chain resources (low-cost flower, oil, distillate) Describe the cannabis laws in your state and country that relate to your Company California has a highly regulated system in place for recreational cannabis sales. https://cannabis.ca.gov/laws-regulations/ Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? We’ll likely accelerate our expansion plans and take advantage of deregulated supply chain opportunities. What else? Is there anything else you’d like to share with investors to help them consider your investment? That should be it!

Explore more information about Guild Extracts at https://breezeinvesting.com/2008

24

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.landracebio.com Entrepreneur John DeMoss johndemoss@landracebio.com Round Overview Current Round: Series A Company Stage: Between $500k and $1M in revenue Raised In This Round: $2,000,000 Capital Seeking: $2,000,000 Direct Investment Min.: $250,000 Valuation: $13,300,000 Security Type: Preferred Equity Touching the plant: no Company Team Noi Obias, PhD – Chief Science Officer Kirsten Anderberg, CPA, MBA – CFO Mel Tipa – Director of QA Enrique Vizoso, MBA – COO John DeMoss, CFA – CEO Full time employees: 23 Social LinkedIn: https://www.linkedin.com/company/ landrace-bioscience/

Landrace Bioscience, Inc.

Biotechnology/Pharmaceutical – Chattanooga - Tennessee - US

company summary

What customer problem does your product/ service address? Existing manufacturers seeking to enter the CBD/Hemp market face many challenges and uncertainties. Hemp extract is not soluble in water based products, can be fairly unstable, can have a bad taste, is viscous, high variance in bioavailability depending on formulation, etc. There is limited information on safety and efficacy, though that data pool is growing. It is virtually impossible for a CP... Describe your product/service and detail the key customer benefits Landrace provides hemp extracts manufactured in a GMP facility with a heavy science focus. We provide product development consulting services Landrace has gone out of its way to recruit top talent. Whether you are looking at us operationally or from the standpoint of our advisory board, we have a world class team, with a heavy focus on science. Our CFO comes from national food manufacturing. Our CSO (PhD) comes from Pharma and 15 years of consumer packaged good formulation. Our Director of QA comes from Biotech. Our Sales team is coached by a former head of global sales for a well-recognized supplement company. Our COO comes from big (900 EEs) and small companies in manufacturing. Our CEO has founded, built and sold a company. Our advisory board contains PhDs, MDs and entrepreneurs with global recognition. Our company differentiates itself in the market by bringing an unprecedented level of technical and product development expertise to our target customer: the existing manufacturer that seeks to begin working with CBD or hemp extract. In doing so, Landrace also creates valuable IP. executive summary

Landrace is a hemp ingredient manufacturer addressing the needs of existing manufacturers in their product development efforts.

25

The Arcview Group / Las Vegas, NV - 12.10.2019

as part of a supply agreement. We will be pursuing some very interesting research projects through a subsidiary JV that will further underscore the brand’s commitment to truth and potentially create very valuable IP in the process. Describe the competitive landscape and your competitor’s strengths and weaknesses Competitors range from potheads who got money somehow to a few seasoned business-minded professionals seeking to do things according to a differentiated strategy. Largely, competitors are turning to a focus on volume. This makes it very difficult to have many players survive. Describe what makes your solution unique, and what your competitive advantages are We look to create brand equity through real and tangible scientific endeavors, supporting extract sales. Extract sales are merely the engine that drives IP creation, which is where we believe the real value is. IP development (through internal efforts, JV efforts, or contractually with customers), brand equity and premium extract status are mutually supportive endeavors. Describe your target market, and who your customers are, and why you’re targeting them Target customers are existing manufacturers who already have distribution and a customer base in place. They are doing $10 - 250MM in sales already. As Landrace grows there is no reason we could not increase that range. How will you use investment capital to grow your business, and what would the key milestones of success be? Cash flow positive. Finish a limited amount of Capex, improve inventory levels of raw goods and finished goods. Besides capital, what are you seeking from investors and potential strategic partners? Relationships with distribution, manufacturing and science. Describe the cannabis laws in your state and country that relate to your Company Hemp is legal. Processors do not need a license in TN. No medical or adult use at this point. Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? Likely. We will cross that bridge at that point. We will likely be the largest and definitely the most capable group in the state. Whether that needs to be a NewCo in a different facility or can be blended into existing infrastructure is something that is not clear yet.

Explore more information about Landrace Bioscience at https://breezeinvesting.com/1997

26

The Arcview Group / Las Vegas, NV - 12.10.2019

Company www.pineappleexpressdelivery.com Entrepreneur Randy Rolph randy@pineappleexpressdelivery.com Round Overview Current Round: Other Company Stage: Under $500k in revenue Raised In This Round: $0 Capital Seeking: $1,500,000 Direct Investment Min.: $500,000

Pineapple Express Delivery Distribution – Burlington - Ontario - CA

Valuation: $4,800,000 Security Type: Other Touching the plant: no

company summary

Our company is the most compliant and unique same day logistics solution for the Cannabis Industry . We operate across Canada with approximately 70% of the market . We are the only company that provides full scale end to end logistics solutions, from same day delivery to medical and recreational customers from LP’s , a robust B2B solution, interprovincial distribution and full scale testing logistics solutions.

Company Team Randy Rolph – CEO Full time employees: 17 Social Facebook: https://www.facebook.com/ pxdeliverycanada/

executive summary

What customer problem does your product/ service address? Customers seeking a same day cannabis and cannabis related product delivery service. Describe your product/service and detail the key customer benefits We provide same day cannabis delivery to a customer’s door quickly and discreetly. Key customer benefits include not having to leave the comfort of one’s home and discreet delivery. Describe the competitive landscape and your competitor’s strengths and weaknesses We are (to our knowledge) the only same day cannabis delivery company in Canada and the most compliant. Our drivers are required to have clean driving and criminal records and are fully insured. Describe what makes your solution unique, and what your competitive advantages are We have the “first mover” advantage in Canada and recruit and train the best talent. We do this by offering one of the most competitive compensation packages in the industry.

Same day logistics solution for the Cannabis Industry

27

The Arcview Group / Las Vegas, NV - 12.10.2019

Describe your target market, and who your customers are, and why you’re targeting them Our target market includes both recreational and medical cannabis users. How will you use investment capital to grow your business, and what would the key milestones of success be? We want to hire an operations VP and outfit a distribution hub in Burlington, ON that will store medical cannabis products and act as a distribution centre for southern Ontario. Besides capital, what are you seeking from investors and potential strategic partners? We believe that we have the necessary skills and expertise relating to the cannabis industry in-house and need capital at this time to continue operations and get us to a profitable position which is estimated to be in March of 2020 with this investment. Describe the cannabis laws in your state and country that relate to your Company They vary from province to province. Thus we have engaged legal counsel to ensure we are fully compliant in all jurisdictions that we operate. Will your Company’s plans change when cannabis becomes legal for recreational use in your state and/or country? Recreational cannabis is already legal in all Canadian provinces. What else? Is there anything else you’d like to share with investors to help them consider your investment? We are a young, diverse and energetic team looking to provide a unique, professional experience to both recreational and medicinal cannabis users across our country.

Explore more information about Pineapple Express Delivery at https://breezeinvesting.com/2012

Page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 Page 10 Page 11 Page 12 Page 13 Page 14 Page 15 Page 16 Page 17 Page 18 Page 19 Page 20 Page 21 Page 22 Page 23 Page 24 Page 25 Page 26 Page 27 Page 28 Page 29 Page 30 Page 31 Page 32

arcviewgroup.com

Made with FlippingBook - Online catalogs